Author

N. Caronni

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1

Frequent Co-Authors

F. Benvenuti· 2 shared G. M. Piperno· 2 shared A. Bardelli· 1 shared A. Cappelletto· 1 shared C. Volponi· 1 shared D. Lazarevic· 1 shared F. Giannese· 1 shared F. La Terza· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

F. Benvenuti

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

DCs targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors

L. Lopez, L. G. Morosi, F. La Terza, P. Bourdely, G. Rospo, R. Amadio, G. M. Piperno, V. Russo, C. Volponi, S. Vodret, S. Joshi, F. Giannese, D. Lazarevic, G. Germano, P. Stoitzner, , F. Benvenuti

The paper shows that DC-based therapy enhances CD8 T cell responses to neoantigens in lung tumors, particularly in high TMB tumors.

bioRxiv · Jan 26, 2024 · PreprintImmunology

SiglecFhigh neutrophils in lung tumor tissues suppress local CD8 T cell responses and limit the efficacy of anti PD-L1 antibodies

F. Simoncello, G. M. Piperno, N. Caronni, T. Battini, A. Cappelletto, S. Bicciato, F. Benvenuti

This study shows that SiglecFhigh neutrophils in lung tumors suppress CD8 T cell responses and reduce the effectiveness of anti-PD-L1 therapy.

bioRxiv · Oct 21, 2021 · PreprintImmunology